A common polymorphism (R577X) in the ACTN3 gene results in complete deficiency of ␣-actinin-3 protein in ϳ16% of humans worldwide. The presence of ␣-actinin-3 protein is associated with improved sprint/power performance in athletes and the general population. Despite this, there is evidence that the null genotype XX has been acted on by recent positive selection, likely due to its emerging role in the regulation of muscle metabolism. ␣-Actinin-3 deficiency reduces the activity of glycogen phosphorylase and results in a fundamental shift toward more oxidative pathways of energy utilization. Deficiency of the fast-fiber skeletal muscle protein ␣-actinin-3 is common in the general population due to a polymorphic-null allele in the ACTN3 gene. Numerous independent studies have established that the absence of ␣-actinin-3 is detrimental to sprint and power performance in athletes and in the general population (1,25,55,63,66). The sarcomeric ␣-actinins have long been considered to be primarily structural proteins. However, recent data suggest that ␣-actinin-3 plays a significant role in the regulation of muscle metabolism. ␣-Actinin-3 deficiency results in a shift in the characteristics of fast glycolytic muscle fibers toward those of slow muscle fibers with oxidative metabolism (48,49,62). This review examines the emerging role of ␣-actinin-3 in regulation of skeletal muscle metabolism.
The ␣-Actinin Family of ProteinsThe ␣-actinins are a family of actin-binding proteins that have been identified in a diverse range of organisms, suggesting an ancient origin (3,8,33,50). The ␣-actinin protein structure is comprised of three domains; an NH 2 -terminal actin-binding domain, a central rod domain containing four internal repeated 122-amino acid motifs, and a COOH-terminal region containing two EF-hand calcium binding motifs. The four repetitive motifs found in ␣-actinin share homology with spectrin, suggesting a common evolutionary origin of the ␣-actinin proteins and the spectrin family of actin binding cytoskeletal proteins, of which dystrophin is a member (13, 75). There is marked evolutionary conservation of the ␣-actinin genes across species, particularly within the NH 2 -terminal actin-binding domain (9). There are four ␣-actinin genes in humans, ACTN1-ACTN4 (9, 85). ACTN1 and ACTN4 contain functional calcium-sensitive EF hands, whereas the skeletal muscle or sarcomeric ␣-actinins, encoded by ACTN2 and ACTN3, have EF hands that are not calcium sensitive (15). In humans, ␣-actinin-2 is expressed in the heart, in all skeletal muscle fibers, and in the brain, whereas ␣-actinin-3 is expressed only in fast glycolytic skeletal muscle fibers, is not present in cardiac muscle, and has low levels of expression in the brain (50). These two proteins diverged from one another following a gene duplication event over 300 million years ago (mya), but have retained considerable sequence similarity (43). Human ␣-actinin-2 and ␣-actinin-3 are 79% identical and 91% similar at the amino acid level (9, 42).The sarcomeres are repeating un...